{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T19:22:54Z","timestamp":1787685774940,"version":"build-2784847793"},"reference-count":107,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2022-00799"],"award-info":[{"award-number":["2022-00799"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.expneurol.2026.115891","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T06:43:29Z","timestamp":1782283409000},"page":"115891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Programmed axon degeneration gene variants in human disease"],"prefix":"10.1016","volume":"404","author":[{"given":"Eleanor L.","family":"Hopkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6194-8397","authenticated-orcid":false,"given":"Pete A.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2026.115891_bb0005","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.6c00352","article-title":"Structure-based discovery of imidazo[4,5-c]pyridine SARM1 modulators showing paradoxical activation","author":"Albanese","year":"2026","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.expneurol.2026.115891_bb0010","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1089\/neu.2022.0416","article-title":"Traumatic axonal injury in the optic nerve: the selective role of SARM1 in the evolution of distal axonopathy","volume":"40","author":"Alexandris","year":"2023","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.expneurol.2026.115891_bb0015","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.tins.2013.07.002","article-title":"NMNATs, evolutionarily conserved neuronal maintenance factors","volume":"36","author":"Ali","year":"2013","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2026.115891_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002472","article-title":"NMNAT2:HSP90 complex mediates proteostasis in proteinopathies","volume":"14","author":"Ali","year":"2016","journal-title":"PLoS Biol."},{"key":"10.1016\/j.expneurol.2026.115891_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.103812","article-title":"SARM1 is a multi-functional NAD(P)ase with prominent base exchange activity, all regulated bymultiple physiologically relevant NAD metabolites","volume":"25","author":"Angeletti","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.expneurol.2026.115891_bb0030","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1007\/s12035-024-04480-2","article-title":"Chronically low NMNAT2 expression causes sub-lethal SARM1 activation and altered response to nicotinamide riboside in axons","volume":"62","author":"Antoniou","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2026.115891_bb0035","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1007\/s13311-021-01125-3","article-title":"Lessons from injury: how nerve injury studies reveal basic biological mechanisms and therapeutic opportunities for peripheral nerve diseases","volume":"18","author":"Arthur-Farraj","year":"2021","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.expneurol.2026.115891_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2012.06.021","article-title":"C-Jun reprograms Schwann cells of injured nerves to generate a repair cell essential for regeneration","volume":"75","author":"Arthur-Farraj","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2026.115891_bb0045","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2202-6-6","article-title":"The progressive nature of Wallerian degeneration in wild-type and slow Wallerian degeneration (WldS) nerves","volume":"6","author":"Beirowski","year":"2005","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.expneurol.2026.115891_bb0050","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.54.1.20","article-title":"Detection and cellular localization of enterovirus RNA sequences in spinal cord of patients with ALS","volume":"54","author":"Berger","year":"2000","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115891_bb0055","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-43514-6","article-title":"NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson\u2019s disease","volume":"14","author":"Berven","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2026.115891_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-021-00511-x","article-title":"Constitutively active SARM1 variants that induce neuropathy are enriched in ALS patients","volume":"17","author":"Bloom","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.expneurol.2026.115891_bb0065","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awaa130","article-title":"NAD(P)HX dehydratase protein-truncating mutations are associated with neurodevelopmental disorder exacerbated by acute illness","volume":"143","author":"Borna","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2026.115891_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2022.02.001","article-title":"The NADPARK study: a randomized phase I trial of nicotinamide riboside supplementation in Parkinson\u2019s disease","volume":"34","author":"Brakedal","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.expneurol.2026.115891_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107999","article-title":"Structural and mechanistic regulation of the pro-degenerative NAD hydrolase SARM1","volume":"32","author":"Bratkowski","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.expneurol.2026.115891_bb0080","doi-asserted-by":"crossref","DOI":"10.1038\/ni1382","article-title":"The human adaptor SARM negatively regulates adaptor protein TRIF-dependent toll-like receptor signaling - PubMed","volume":"7","author":"Carty","year":"2006","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.expneurol.2026.115891_bb0085","doi-asserted-by":"crossref","DOI":"10.1023\/A:1023067728557","article-title":"Risk of sporadic amyotrophic lateral sclerosis associated with seropositivity for herpesviruses and echovirus-7 - PubMed","volume":"18","author":"Cermelli","year":"2003","journal-title":"Eur. J. Epidemiol."},{"issue":"9","key":"10.1016\/j.expneurol.2026.115891_bb0090","doi-asserted-by":"crossref","DOI":"10.1038\/ng.2370","article-title":"Exome sequencing identifies NMNAT1 mutations as a cause of Leber congenital amaurosis","volume":"44","author":"Chiang","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2026.115891_bb0095","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41583-020-0269-3","article-title":"Programmed axon degeneration: from mouse to mechanism to medicine","volume":"21","author":"Coleman","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2026.115891_bb0100","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1111\/j.1742-4658.2011.08193.x","article-title":"Reducing expression of NAD+ synthesizing enzyme NMNAT1 does not affect the rate of Wallerian degeneration","volume":"278","author":"Conforti","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.expneurol.2026.115891_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.860410","article-title":"SARM1 depletion slows axon degeneration in a CNS model of neurotropic viral infection","volume":"15","author":"Crawford","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.expneurol.2026.115891_bb0110","article-title":"Quantification of SARM1 activity in human peripheral blood mononuclear cells","author":"Dabill","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.expneurol.2026.115891_bb0115","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.131093","article-title":"Human endogenous retrovirus HERV-K(HML-2) RNA causes neurodegeneration through toll-like receptors","volume":"5","author":"Dembny","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.expneurol.2026.115891_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2010.04.003","article-title":"Unique expression pattern of human nicotinamide mononucleotide adenylyltransferase isozymes in red blood cells - PubMed","volume":"45","author":"Di Stefano","year":"2010","journal-title":"Blood Cells Mol. Dis."},{"issue":"5","key":"10.1016\/j.expneurol.2026.115891_bb0125","doi-asserted-by":"crossref","DOI":"10.1038\/cdd.2014.164","article-title":"A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration","volume":"22","author":"Di Stefano","year":"2014","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.expneurol.2026.115891_bb0130","doi-asserted-by":"crossref","DOI":"10.1172\/JCI159800","article-title":"Macrophage depletion blocks congenital SARM1-dependent neuropathy","volume":"132","author":"Dingwall","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2026.115891_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/ana.22149","article-title":"Identification of active loci of a human endogenous retrovirus in neurons of patients with amyotrophic lateral sclerosis","volume":"69","author":"Douville","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2026.115891_bb0140","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.neuron.2017.02.022","article-title":"The SARM1 toll\/interleukin-1 receptor domain possesses intrinsic NAD(+) cleavage activity that promotes pathological axonal degeneration","volume":"93","author":"Essuman","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2026.115891_bb0145","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/ng.2361","article-title":"NMNAT1 mutations cause Leber congenital amaurosis","volume":"44","author":"Falk","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2026.115891_bb0150","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.neuron.2021.02.009","article-title":"SARM1 is a metabolic sensor activated by an increased NMN\/NAD(+) ratio to trigger axon degeneration","volume":"109","author":"Figley","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2026.115891_bb0155","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/iub.2584","article-title":"The key role of the NAD biosynthetic enzyme nicotinamide mononucleotide adenylyltransferase in regulating cell functions","volume":"74","author":"Fortunato","year":"2022","journal-title":"IUBMB Life"},{"key":"10.1016\/j.expneurol.2026.115891_bb0160","doi-asserted-by":"crossref","first-page":"13569","DOI":"10.1523\/JNEUROSCI.1197-13.2013","article-title":"Sarm1-mediated axon degeneration requires both SAM and TIR interactions","volume":"33","author":"Gerdts","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2026.115891_bb0165","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1126\/science.1258366","article-title":"SARM1 activation triggers axon degeneration locally via NAD(+) destruction","volume":"348","author":"Gerdts","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2026.115891_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000300","article-title":"Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons","volume":"8","author":"Gilley","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.expneurol.2026.115891_bb0175","doi-asserted-by":"crossref","first-page":"13410","DOI":"10.1523\/JNEUROSCI.1534-13.2013","article-title":"Rescue of peripheral and CNS axon defects in mice lacking NMNAT2","volume":"33","author":"Gilley","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2026.115891_bb0180","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.celrep.2015.02.060","article-title":"Absence of SARM1 rescues development and survival of NMNAT2-deficient axons","volume":"10","author":"Gilley","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.expneurol.2026.115891_bb0185","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/hmg\/ddy356","article-title":"Low levels of NMNAT2 compromise axon development and survival","volume":"28","author":"Gilley","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2026.115891_bb0190","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.70905","article-title":"Enrichment of SARM1 alleles encoding variants with constitutively hyperactive NADase in patients with ALS and other motor nerve disorders","volume":"10","author":"Gilley","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.expneurol.2026.115891_bb0195","doi-asserted-by":"crossref","first-page":"6558","DOI":"10.1021\/acs.jmedchem.4c03127","article-title":"Discovery of a potent SARM1 base-exchange inhibitor with in vivo efficacy","volume":"68","author":"Giroud","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.expneurol.2026.115891_bb0200","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1021\/acsmedchemlett.5c00189","article-title":"Optimization of brain penetrant SARM1 orthosteric inhibitors and discovery of their paradoxical subinhibitory activation","volume":"16","author":"Green","year":"2025","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.expneurol.2026.115891_bb0205","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/aww001","article-title":"Attenuated traumatic axonal injury and improved functional outcome after traumatic brain injury in mice lacking Sarm1 - PubMed","volume":"139","author":"Henninger","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2026.115891_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047869","article-title":"Nicotinamide mononucleotide adenylyltransferase 2 (Nmnat2) regulates axon integrity in the mouse embryo","volume":"7","author":"Hicks","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2026.115891_bb0215","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M114.554378","article-title":"Deficiency of nicotinamide mononucleotide adenylyltransferase 3 (Nmnat3) causes hemolytic anemia by altering the glycolytic flow in mature erythrocytes","volume":"289","author":"Hikosaka","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2026.115891_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.703532","article-title":"A novel NAD signaling mechanism in axon degeneration and its relationship to innate immunity","volume":"8","author":"Hopkins","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.expneurol.2026.115891_bb0225","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/ceo.13818","article-title":"Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: a crossover randomized clinical trial","volume":"48","author":"Hui","year":"2020","journal-title":"Clin. Experiment. Ophthalmol."},{"key":"10.1016\/j.expneurol.2026.115891_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.112958","article-title":"Homozygous NMNAT2 mutation in sisters with polyneuropathy and erythromelalgia","volume":"320","author":"Huppke","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2026.115891_bb0235","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/s41586-020-2862-z","article-title":"The NAD(+)-mediated self-inhibition mechanism of pro-neurodegenerative SARM1","volume":"588","author":"Jiang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2026.115891_bb0240","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3177\/jnsv.69.184","article-title":"Deletion of Nmnat1 in skeletal muscle leads to the reduction of NAD(+) levels but has no impact on skeletal muscle morphology and fiber types","volume":"69","author":"Karim","year":"2023","journal-title":"J. Nutr. Sci. Vitaminol. (Tokyo)"},{"key":"10.1016\/j.expneurol.2026.115891_bb0245","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/ng.2356","article-title":"Mutations in NMNAT1 cause Leber congenital amaurosis and identify a new disease pathway for retinal degeneration","volume":"44","author":"Koenekoop","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2026.115891_bb0250","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.ajhg.2016.07.018","article-title":"NAXE mutations disrupt the cellular NAD(P)HX repair system and cause a lethal neurometabolic disorder of early childhood","volume":"99","author":"Kremer","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.expneurol.2026.115891_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.06.005","article-title":"Emerging therapeutic developments in neurodegenerative diseases: a clinical investigation","volume":"27","author":"Kumar","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.expneurol.2026.115891_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2019.09.001","article-title":"NAD+ in brain aging and neurodegenerative disorders","volume":"30","author":"Lautrup","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.expneurol.2026.115891_bb0265","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2026.115891_bb0270","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac8201","article-title":"Human endogenous retrovirus-K contributes to motor neuron disease","volume":"7","author":"Li","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.expneurol.2026.115891_bb0275","article-title":"Permeant fluorescent probes visualize the activation of SARM1 and uncover an anti-neurodegenerative drug candidate","volume":"10","author":"Li","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.expneurol.2026.115891_bb0280","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202501072","article-title":"SCFFBXO21-mediated ubiquitination and degradation of NMNAT2 regulates axon survival in nerve injury","volume":"224","author":"Long","year":"2025","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.expneurol.2026.115891_bb0285","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0006-8993(82)91199-4","article-title":"Patterns of Wallerian degeneration of myelinated fibres in short and long peripheral stumps and in isolated segments of rat phrenic nerve. Interpretation of the role of axoplasmic flow of the trophic factor","volume":"233","author":"Lubinska","year":"1982","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2026.115891_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.112961","article-title":"Severe biallelic loss-of-function mutations in nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2) in two fetuses with fetal akinesia deformation sequence","volume":"320","author":"Lukacs","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2026.115891_bb0295","article-title":"The rise and fall of SARM1 base-exchange inhibitors","author":"Lundb\u00e4ck","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.expneurol.2026.115891_bb0300","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1093\/brain\/awac065","article-title":"Niacin therapy improves outcome and normalizes metabolic abnormalities in an NAXD-deficient patient","volume":"145","author":"Manor","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2026.115891_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.113040","article-title":"Sarm1 deletion reduces axon damage, demyelination, and white matter atrophy after experimental traumatic brain injury","volume":"321","author":"Marion","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2026.115891_bb0310","series-title":"GeneReviews","author":"Mark","year":"2023"},{"key":"10.1016\/j.expneurol.2026.115891_bb0315","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/s41588-019-0528-2","article-title":"PanelApp crowdsources expert knowledge to establish consensus diagnostic gene panels","volume":"51","author":"Martin","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2026.115891_bb0320","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.tins.2021.10.014","article-title":"Mitochondrial dysfunction as a trigger of programmed axon death","volume":"45","author":"Merlini","year":"2022","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2026.115891_bb0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2010.12.006","article-title":"The Wlds transgene reduces axon loss in a Charcot-Marie-Tooth disease 1A rat model and nicotinamide delays post-traumatic axonal degeneration","volume":"42","author":"Meyer zu Horste","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2026.115891_bb0330","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1006\/geno.2001.6548","article-title":"A novel human gene (SARM) at chromosome 17q11 encodes a protein with a SAM motif and structural similarity to Armadillo\/beta-catenin that is conserved in mouse, Drosophila, and Caenorhabditis elegans","volume":"74","author":"Mink","year":"2001","journal-title":"Genomics"},{"key":"10.1016\/j.expneurol.2026.115891_bb0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113939","article-title":"Metabolic profiling of alternative NAD biosynthetic routes in mouse tissues","volume":"9","author":"Mori","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2026.115891_bb0340","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41431-017-0029-7","article-title":"NMNAT1 variants cause cone and cone-rod dystrophy","volume":"26","author":"Nash","year":"2018","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.expneurol.2026.115891_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.cub.2012.07.024","article-title":"Ageing as a risk factor for disease","volume":"22","author":"Niccoli","year":"2012","journal-title":"Curr. Biol."},{"key":"10.1016\/j.expneurol.2026.115891_bb0350","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S1471-4906(03)00115-7","article-title":"The toll-IL-1 receptor adaptor family grows to five members","volume":"24","author":"O\u2019Neill","year":"2003","journal-title":"Trends Immunol."},{"key":"10.1016\/j.expneurol.2026.115891_bb0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053271","article-title":"Simultaneous single-sample determination of NMNAT isozyme activities in mouse tissues","volume":"7","author":"Orsomando","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2026.115891_bb0360","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.1223899","article-title":"dSarm\/Sarm1 is required for activation of an injury-induced axon death pathway","volume":"337","author":"Osterloh","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2026.115891_bb0365","doi-asserted-by":"crossref","DOI":"10.1038\/ng.2357","article-title":"Mutations in NMNAT1 cause Leber congenital amaurosis with early-onset severe macular and optic atrophy - PubMed","volume":"44","author":"Perrault","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2026.115891_bb0370","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2025030958","article-title":"NMNAT3 deficiency: a novel red blood cell enzymopathy causing hemolysis by altering NAD levels and glycolysis","volume":"146","author":"Ruiter","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.expneurol.2026.115891_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2023.02.001","article-title":"NMNAT1 and hereditary spastic paraplegia (HSP): expanding the phenotypic spectrum of NMNAT1 variants","volume":"33","author":"Sadr","year":"2023","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.expneurol.2026.115891_bb0380","doi-asserted-by":"crossref","first-page":"17228","DOI":"10.1074\/jbc.M115.637850","article-title":"Characterization of Leber congenital amaurosis-associated NMNAT1 mutants","volume":"290","author":"Sasaki","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2026.115891_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113252","article-title":"cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons","volume":"329","author":"Sasaki","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2026.115891_bb0390","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.62027","article-title":"SARM1 depletion rescues NMNAT1-dependent photoreceptor cell death and retinal degeneration","volume":"9","author":"Sasaki","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.expneurol.2026.115891_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113842","article-title":"Nicotinic acid mononucleotide is an allosteric SARM1 inhibitor promoting axonal protection","volume":"345","author":"Sasaki","year":"2021","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2026.115891_bb0400","doi-asserted-by":"crossref","DOI":"10.1172\/JCI161566","article-title":"A SARM1-mitochondrial feedback loop drives neuropathogenesis in a Charcot-Marie-Tooth disease type 2A rat model","volume":"132","author":"Sato-Yamada","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2026.115891_bb0405","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJMoa1616361","article-title":"NAD deficiency, congenital malformations, and niacin supplementation","volume":"377","author":"Shi","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2026.115891_bb0410","first-page":"753","article-title":"Novel compound heterozygous NMNAT1 variants associated with Leber congenital amaurosis","volume":"20","author":"Siemiatkowska","year":"2014","journal-title":"Mol. Vis."},{"key":"10.1016\/j.expneurol.2026.115891_bb0415","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.1049653","article-title":"Nicotinamide riboside kinases regulate skeletal muscle fiber-type specification and are rate-limiting for metabolic adaptations during regeneration","volume":"10","author":"Sonntag","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.expneurol.2026.115891_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(24)00038-3","article-title":"Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: a systematic analysis for the global burden of disease study 2021","volume":"23","author":"Steinmetz","year":"2024","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2026.115891_bb0425","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008343","article-title":"Novel role of SARM1 mediated axonal degeneration in the pathogenesis of rabies","volume":"16","author":"Sundaramoorthy","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.expneurol.2026.115891_bb0430","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ajhg.2019.12.006","article-title":"Bi-allelic mutations in NADSYN1 cause multiple organ defects and expand the genotypic spectrum of congenital NAD deficiency disorders","volume":"106","author":"Szot","year":"2020","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.expneurol.2026.115891_bb0435","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/humu.24211","article-title":"New cases that expand the genotypic and phenotypic spectrum of congenital NAD deficiency disorder","volume":"42","author":"Szot","year":"2021","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.expneurol.2026.115891_bb0440","doi-asserted-by":"crossref","DOI":"10.1172\/JCI174824","article-title":"A metabolic signature for NADSYN1-dependent congenital NAD deficiency disorder","volume":"134","author":"Szot","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2026.115891_bb0445","doi-asserted-by":"crossref","first-page":"9329","DOI":"10.1128\/JVI.00836-09","article-title":"The immune adaptor molecule SARM modulates tumor necrosis factor alpha production and microglia activation in the brainstem and restricts West Nile virus pathogenesis","volume":"83","author":"Szretter","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.expneurol.2026.115891_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101988","article-title":"Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction","volume":"43","author":"Tribble","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.expneurol.2026.115891_bb0455","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40478-023-01513-0","article-title":"NAD salvage pathway machinery expression in normal and glaucomatous retina and optic nerve","volume":"11","author":"Tribble","year":"2023","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.expneurol.2026.115891_bb0460","doi-asserted-by":"crossref","first-page":"6256","DOI":"10.1038\/s41467-024-50354-5","article-title":"NMNAT2 is a druggable target to drive neuronal NAD production","volume":"15","author":"Tribble","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2026.115891_bb0465","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2217\/17460794.3.6.579","article-title":"Axonal degeneration as a self-destructive defense mechanism against neurotropic virus infection","volume":"3","author":"Tsunoda","year":"2008","journal-title":"Future Virol."},{"key":"10.1016\/j.expneurol.2026.115891_bb0470","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/brain\/awy310","article-title":"NAD(P)HX dehydratase (NAXD) deficiency: a novel neurodegenerative disorder exacerbated by febrile illnesses","volume":"142","author":"Van Bergen","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2026.115891_bb0475","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/jimd.12541","article-title":"Clinical and biochemical distinctions for a metabolite repair disorder caused by NAXD or NAXE deficiency","volume":"45","author":"Van Bergen","year":"2022","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.expneurol.2026.115891_bb0480","doi-asserted-by":"crossref","DOI":"10.3109\/17482960903262083","article-title":"Cerebrospinal fluid detection of enterovirus genome in ALS: a study of 242 patients and 354 controls","volume":"11","author":"Vandenberghe","year":"2010","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.expneurol.2026.115891_bb0485","doi-asserted-by":"crossref","DOI":"10.1126\/science.aac4854","article-title":"NAD+ in aging, metabolism, and neurodegeneration","volume":"350","author":"Verdin","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2026.115891_bb0490","first-page":"423","article-title":"Experiments on the section of the glossopharyngeal and hypoglossal nerves of the frog, and observations of the alterations produced thereby in the structure of their primitive fibres","volume":"140","author":"Waller","year":"1850","journal-title":"Philos. Trans. R. Soc. Lond."},{"key":"10.1016\/j.expneurol.2026.115891_bb0495","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/j.celrep.2017.08.022","article-title":"Deletion of Nampt in projection neurons of adult mice leads to motor dysfunction, neurodegeneration, and death","volume":"20","author":"Wang","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.expneurol.2026.115891_bb0500","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/jnc.14878","article-title":"Subcellular NAMPT-mediated NAD(+) salvage pathways and their roles in bioenergetics and neuronal protection after ischemic injury","volume":"151","author":"Wang","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2026.115891_bb0505","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1126\/science.aal0092","article-title":"Vitamin B(3) modulates mitochondrial vulnerability and prevents glaucoma in aged mice","volume":"355","author":"Williams","year":"2017","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.expneurol.2026.115891_bb0510","article-title":"NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.expneurol.2026.115891_bb0515","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-71906-x","article-title":"Regulation of degenerative spheroids after injury","volume":"10","author":"Yong","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2026.115891_bb0520","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.908148","article-title":"Myelin clearance is critical for regeneration after peripheral nerve injury","volume":"13","author":"Yuan","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.expneurol.2026.115891_bb0525","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40478-024-01736-9","article-title":"Loss of Sarm1 reduces retinal ganglion cell loss in chronic glaucoma","volume":"12","author":"Zeng","year":"2024","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.expneurol.2026.115891_bb0530","article-title":"A sensory and motor neuropathy caused by a genetic variant of NAMPT","volume":"11","author":"Zhang","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.expneurol.2026.115891_bb0535","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awz375","article-title":"NAD(P)HX dehydratase (NAXD) deficiency: a novel neurodegenerative disorder exacerbated by febrile illnesses","volume":"143","author":"Zhou","year":"2020","journal-title":"Brain"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488626002566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488626002566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T11:13:53Z","timestamp":1786014833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488626002566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":107,"alternative-id":["S0014488626002566"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2026.115891","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Programmed axon degeneration gene variants in human disease","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2026.115891","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115891"}}